HABA Laboratories,Inc. (TYO:4925)
1,706.00
+2.00 (0.12%)
May 29, 2026, 3:30 PM JST
HABA Laboratories,Inc. Revenue
In the fiscal year ending March 31, 2026, HABA Laboratories,Inc. had annual revenue of 12.14B JPY with 0.66% growth. HABA Laboratories,Inc. had revenue of 3.42B in the quarter ending March 31, 2026, a decrease of -0.84%.
Revenue
12.14B
Revenue Growth
+0.66%
P/S Ratio
0.53
Revenue / Employee
21.38M
Employees
568
Market Cap
6.45B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 12.14B | 80.00M | 0.66% |
| Mar 31, 2025 | 12.06B | -263.00M | -2.13% |
| Mar 31, 2024 | 12.32B | 286.00M | 2.38% |
| Mar 31, 2023 | 12.04B | -870.00M | -6.74% |
| Mar 31, 2022 | 12.91B | -1.40B | -9.78% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Niitaka | 24.13B |
| SHOBIDO | 22.85B |
| Premier Anti-Aging | 14.97B |
| AXXZIA | 13.97B |
| Axas Holdings | 12.48B |
| Kitanotatsujin | 11.21B |
| Liberta | 10.29B |
| Almado | 10.12B |